VANGL2 and breast carcinoma: The MMTV-NDL murine model was selected based on our observations that Vangl2 is highly expressed in tumors from this model (Additional file 4: Fig. S1b) and Vangl2 overexpression was observed in breast cancer patient tumors of all molecular subtypes [31].